-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51

Benzinga·10/14/2026 17:28:03
Listen to the news
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $51.